Management of transfusional iron overload &ndash; differential properties and efficacy of iron chelating agents

Management of transfusional iron overload &ndash; differential properties and efficacy of iron chelating agents

Janet L Kwiatkowski The Children&#39;s Hospital of Philadelphia, Division of Hematology and University of Pennsylvania School of Medicine, Philadelphia, PA, USA Abstract: Regular red cell transfusion therapy ameliorates disease-related morbidity and can be lifesaving in patients with various...

Full description

Bibliographic Details
Main Author:	Kwiatkowski JL
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-09-01
Series:	Journal of Blood Medicine
Online Access:	http://www.dovepress.com/management-of-transfusional-iron-overload-ndash-differential-propertie-a8330

Similar Items

Innovative polymeric iron chelators with iron binding affinity and biocompatibility for the treatment of transfusional iron overload.
by: Hamilton, Jasmine La Juanie
Published: (2015)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
by: Alexandros Makis, et al.
Published: (2013-01-01)

Iron chelating agents for iron overload diseases
by: Guido Crisponi, et al.
Published: (2014-09-01)

Assessment of new iron chelating agents for treatment of iron-overload
by: Sarmento, Carlos V., 1980-
Published: (2007)

Transfusional iron overload presenting as choroid plexus hemosiderosis
by: D E Sossa, et al.
Published: (2013-11-01)

IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS
by: Elena Maria Elli, et al.
Published: (2014-05-01)

Comparative study of efficacy of different iron chelating agents in treatment of iron overload in children with Beta Thalassemia Major
by: adel abd elhaleim hagag
Published: (2014-08-01)

Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
by: Naser Mobarra, et al.
Published: (2016-10-01)

The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes
by: Emmanouil Petrou, et al.
Published: (2015-08-01)

Deferasirox, an oral chelator in the treatment of iron overload
by: I. Portioli
Published: (2013-05-01)

Controversies on the Consequences of Iron Overload and Chelation in MDS
by: Francesca Vinchi, et al.
Published: (2020-06-01)

Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.
by: Suwakon Wongjaikam, et al.
Published: (2016-01-01)

Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01)

Iron-Chelating Agent Can Maintain Bone Homeostasis Disrupted by Iron Overload by Upregulating Wnt/Beta-Catenin Signaling
by: Wei Xu, et al.
Published: (2020-01-01)

Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
by: Dijiong Wu, et al.
Published: (2019-06-01)

Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
by: Kanjaksha Ghosh, et al.
Published: (2018-01-01)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
by: Rayan Bou-Fakhredin, et al.
Published: (2017-12-01)

Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature
by: Mohamed Belmouhand, et al.
Published: (2021-07-01)

In vivo calibration of the T2* cardiovascular magnetic resonance method at 1.5 T for estimation of cardiac iron in a minipig model of transfusional iron overload
by: Peter Diedrich Jensen, et al.
Published: (2021-03-01)

Subcutaneous desferrioxamine therapy for transfusional overload
by: Hussain, M. A. M.
Published: (1981)

Iron overload and Mycobacterium tuberculosis infection: iron chelation modulates pathogen replication and monocyte-macrophage defence.
by: Cronje, Leandra
Published: (2008)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
by: Parinaz Zarghamian, et al.
Published: (2020-04-01)

Naringin Chelates Excessive Iron and Prevents the Formation of Amyloid-Beta Plaques in the Hippocampus of Iron-Overloaded Mice
by: Mehrdad Jahanshahi, et al.
Published: (2021-07-01)

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major
by: Hossein Karami, et al.
Published: (2017-01-01)

Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators
by: Orish Ebere Orisakwe, et al.
Published: (2020-01-01)

effect of a new metal chelator emeramide on secondary iron overload in mice
Published: ()

The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
by: Lap Shu Alan Chan, et al.
Published: (2021-05-01)

Pharmacogenetic study of deferasirox, an iron chelating agent.
by: Ji Won Lee, et al.
Published: (2013-01-01)

Meta-analysis of the safety of iron chelating agents
by: Li, Niya, et al.
Published: (2015)

Iron Chelation Therapy with Deferasirox Results in Improvement of Liver Enzyme Level in Patients with Iron Overload-Associated Liver Dysfunction
by: Yasuo Miura, et al.
Published: (2010-01-01)

Sobrecarga e quelação de ferro na anemia falciforme Iron overload and iron chelation in sickle cell disease
by: Rodolfo D. Cançado
Published: (2007-09-01)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
by: Eric Grignano, et al.
Published: (2020-09-01)

Single oral dose cure of lethal <it>P. yoelii</it> with a new iron chelator in human clinical trials for iron overload
by: Rienhoff Hugh, et al.
Published: (2010-10-01)

Design and synthesis of hexadentate iron (III) chelating agents
by: Tilbrook, Gary Stuart
Published: (1995)

The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain
by: Robert R. Crichton, et al.
Published: (2019-09-01)

Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
by: Garbowski, M. W.
Published: (2017)

Update on the use of deferasirox in the management of iron overload
by: Ali Taher, et al.
Published: (2009-10-01)

Screening for Iron Overload: Lessons from the HEmochromatosis and IRon Overload Screening (HEIRS) Study
by: Paul C Adams, et al.
Published: (2009-01-01)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
by: C. Lehmann, et al.
Published: (2015-01-01)